These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

210 related articles for article (PubMed ID: 34752557)

  • 21. Switching from twice-daily raltegravir plus tenofovir disoproxil fumarate/emtricitabine to once-daily elvitegravir/cobicistat/emtricitabine/tenofovir disoproxil fumarate in virologically suppressed, HIV-1-infected subjects: 48 weeks data.
    Mills A; Crofoot G; Ortiz R; Rashbaum B; Towner W; Ward D; Brinson C; Kulkarni R; Garner W; Ebrahimi R; Cao H; Cheng A; Szwarcberg J
    HIV Clin Trials; 2014; 15(2):51-6. PubMed ID: 24710918
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Use of a Digital Medication Management System for Effective Assessment and Enhancement of Patient Adherence to Therapy (ReX): Feasibility Study.
    Shtrichman R; Conrad S; Schimo K; Shachar R; Machluf E; Mindal E; Epstein H; Epstein S; Paz A
    JMIR Hum Factors; 2018 Nov; 5(4):e10128. PubMed ID: 30478020
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Emtricitabine/tenofovir disoproxil fumarate.
    Drugs R D; 2004; 5(3):160-1. PubMed ID: 15139777
    [TBL] [Abstract][Full Text] [Related]  

  • 24. 'Digital pills' for mental diseases: an ethical and social analysis of the issues behind the concept.
    de Miguel Beriain I; Morla González M
    J Law Biosci; 2020; 7(1):lsaa040. PubMed ID: 34221420
    [TBL] [Abstract][Full Text] [Related]  

  • 25. First experience with a wireless system incorporating physiologic assessments and direct confirmation of digital tablet ingestions in ambulatory patients with schizophrenia or bipolar disorder.
    Kane JM; Perlis RH; DiCarlo LA; Au-Yeung K; Duong J; Petrides G
    J Clin Psychiatry; 2013 Jun; 74(6):e533-40. PubMed ID: 23842023
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Direct Adherence Measurement Using an Ingestible Sensor Compared With Self-Reporting in High-Risk Cardiovascular Disease Patients Who Knew They Were Being Measured: A Prospective Intervention.
    Thompson D; Mackay T; Matthews M; Edwards J; Peters NS; Connolly SB
    JMIR Mhealth Uhealth; 2017 Jun; 5(6):e76. PubMed ID: 28606895
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Digital Medicine: Innovative Drug-Device Combination as New Measure of Medication Adherence.
    Vallejos X; Wu C
    J Pharm Technol; 2017 Aug; 33(4):137-139. PubMed ID: 34860983
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The science of being a study participant: FEM-PrEP participants' explanations for overreporting adherence to the study pills and for the whereabouts of unused pills.
    Corneli AL; McKenna K; Perry B; Ahmed K; Agot K; Malamatsho F; Skhosana J; Odhiambo J; Van Damme L
    J Acquir Immune Defic Syndr; 2015 Apr; 68(5):578-84. PubMed ID: 25761233
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Effectiveness of Digital Medicines to Improve Clinical Outcomes in Patients with Uncontrolled Hypertension and Type 2 Diabetes: Prospective, Open-Label, Cluster-Randomized Pilot Clinical Trial.
    Frias J; Virdi N; Raja P; Kim Y; Savage G; Osterberg L
    J Med Internet Res; 2017 Jul; 19(7):e246. PubMed ID: 28698169
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Long-term safety and efficacy of emtricitabine and tenofovir alafenamide vs emtricitabine and tenofovir disoproxil fumarate for HIV-1 pre-exposure prophylaxis: week 96 results from a randomised, double-blind, placebo-controlled, phase 3 trial.
    Ogbuagu O; Ruane PJ; Podzamczer D; Salazar LC; Henry K; Asmuth DM; Wohl D; Gilson R; Shao Y; Ebrahimi R; Cox S; Kintu A; Carter C; Das M; Baeten JM; Brainard DM; Whitlock G; Brunetta JM; Kronborg G; Spinner CD;
    Lancet HIV; 2021 Jul; 8(7):e397-e407. PubMed ID: 34197772
    [TBL] [Abstract][Full Text] [Related]  

  • 31. A Low-Power, Low-Cost Ingestible and Wearable Sensing Platform to Measure Medication Adherence and Physiological Signals.
    Weeks WA; Dua A; Hutchison J; Joshi R; Li R; Szejer J; Azevedo RG
    Annu Int Conf IEEE Eng Med Biol Soc; 2018 Jul; 2018():5549-5553. PubMed ID: 30441594
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Effect of Reminder Devices on Medication Adherence: The REMIND Randomized Clinical Trial.
    Choudhry NK; Krumme AA; Ercole PM; Girdish C; Tong AY; Khan NF; Brennan TA; Matlin OS; Shrank WH; Franklin JM
    JAMA Intern Med; 2017 May; 177(5):624-631. PubMed ID: 28241271
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Evaluation of an ingestible telemetric temperature sensor for deep hyperthermia applications.
    Mittal BB; Sathiaseelan V; Rademaker AW; Pierce MC; Johnson PM; Brand WN
    Int J Radiat Oncol Biol Phys; 1991 Oct; 21(5):1353-61. PubMed ID: 1938535
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Bone mineral density in virologically suppressed people aged 60 years or older with HIV-1 switching from a regimen containing tenofovir disoproxil fumarate to an elvitegravir, cobicistat, emtricitabine, and tenofovir alafenamide single-tablet regimen: a multicentre, open-label, phase 3b, randomised trial.
    Maggiolo F; Rizzardini G; Raffi F; Pulido F; Mateo-Garcia MG; Molina JM; Ong E; Shao Y; Piontkowsky D; Das M; McNicholl I; Haubrich R
    Lancet HIV; 2019 Oct; 6(10):e655-e666. PubMed ID: 31578954
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Real-time monitoring and just-in-time intervention for adherence to pre-exposure prophylaxis among men who have sex with men in China: a multicentre RCT study protocol.
    Jin X; Wang H; Li H; Chu Z; Zhang J; Hu Q; Lv W; Huang X; Chen Y; Wang H; He X; Zhang L; Hu Z; Bao R; Li S; Ding H; Geng W; Jiang Y; Shang H; Xu J;
    BMC Public Health; 2020 Jul; 20(1):1160. PubMed ID: 32709230
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Patient-Centered Home Care Using Digital Medicine and Telemetric Data for Hypertension: Feasibility and Acceptability of Objective Ambulatory Assessment.
    DiCarlo LA; Weinstein RL; Morimoto CB; Savage GM; Moon GL; Au-Yeung K; Kim YA
    J Clin Hypertens (Greenwich); 2016 Sep; 18(9):901-6. PubMed ID: 26890041
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Daily and non-daily pre-exposure prophylaxis in African women (HPTN 067/ADAPT Cape Town Trial): a randomised, open-label, phase 2 trial.
    Bekker LG; Roux S; Sebastien E; Yola N; Amico KR; Hughes JP; Marzinke MA; Hendrix CW; Anderson PL; Elharrar V; Stirratt M; Rooney JF; Piwowar-Manning E; Eshleman SH; McKinstry L; Li M; Dye BJ; Grant RM;
    Lancet HIV; 2018 Feb; 5(2):e68-e78. PubMed ID: 28986029
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Testing a Real-Time Tenofovir Urine Adherence Assay for Monitoring and Providing Feedback to Preexposure Prophylaxis in Kenya (PUMA): Protocol for a Pilot Randomized Controlled Trial.
    Drain P; Ngure K; Mugo N; Spinelli M; Chatterjee P; Bacchetti P; Glidden D; Baeten J; Gandhi M
    JMIR Res Protoc; 2020 Apr; 9(4):e15029. PubMed ID: 32238341
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Let Visuals Tell the Story: Medication Adherence in Patients with Type II Diabetes Captured by a Novel Ingestion Sensor Platform.
    Browne SH; Behzadi Y; Littlewort G
    JMIR Mhealth Uhealth; 2015 Dec; 3(4):e108. PubMed ID: 26721413
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Optimal HIV Postexposure Prophylaxis Regimen Completion With Single Tablet Daily Elvitegravir/Cobicistat/Tenofovir Disoproxil Fumarate/Emtricitabine Compared With More Frequent Dosing Regimens.
    Mayer KH; Jones D; Oldenburg C; Jain S; Gelman M; Zaslow S; Grasso C; Mimiaga MJ
    J Acquir Immune Defic Syndr; 2017 Aug; 75(5):535-539. PubMed ID: 28696345
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.